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Background:Mid-dermal elastolysis (MDE) is a rare, yet well-deﬁned clinical and histopathologic entity mani-
fested by ﬁne wrinkling of the skin and mid-dermal loss of elastic ﬁbers. This disease predominantly affects
young to middle-aged Caucasian females and although it has no reported systemic features, it is psychologically
bothersome and can be of great cosmetic concern.
Methods:We report a case of a healthy 45 year-old female with widespread mid-dermal elastolysis. A literature
search using the search terms “mid-dermal elastolysis,” “mid dermal elastolysis,” “middermal elastolysis,” and
“elastophagocytosis” was conducted on Pubmed, using articles published from January 2008 until November
2014 to accompany Gambichler’s comprehensive 1977 to 2009 review of mid-dermal elastolysis. The references
of relevant papers were reviewed and further cases included as appropriate.
Results:We review the clinical features and histological, ultrastructural, and immunohistochemical ﬁndings of
MDE, as well as differential diagnoses. There are 13 new publications of MDE since 2008. The novel ﬁndings
since Gambichler’s review are discussed and pathomechanisms revisited. Interestingly, given the striking female
predominance of MDE, there is no known hormonal role in its etiology.
© 2015 The Authors. Published by Elsevier Inc. on behalf ofWomen's Dermatologic Society. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Fibrillar collagen and elastin are two of the most abundant extracel-
lular matrix constituents, which maintain the structure of the skin
(Scola et al., 2011). The density and spatial alignment of the collagen
and elastin architecture deﬁne the mechanical tissue properties of the
skin, namely laxity, stiffness, and porosity. Elastic ﬁbers, which are
made up of an inner core of cross-linked elastin proteins surrounded
by ﬁbrillin microﬁbrils, form an architecturally distinct meshwork
that confers elastic recoil properties to the skin (Baldwin et al., 2013).
The turnover of elastin in an adult is very low, with its half-life likely
exceeding the lifespan of the individual (Sandberg et al., 1982). This
has clinical implications: Once these ﬁbers are lost, the skin deﬁnitively
loses its elasticity.
Mid-dermal elastolysis (MDE) is an acquired elastic tissue disease
manifested by ﬁne wrinkling of the skin and mid-dermal loss of elastic
ﬁbers. It was ﬁrst described by Shelley and Wood in 1977 as “wrinkles
due to idiopathic loss of mid dermal elastic tissue.” The patient
reported by Shelley and Wood had a history of recurrent, unexplained
urticaria preceding the development of asymptomatic, ﬁnely wrinkled
plaques. A subsequent report by Brenner et al. (1978) described two
morphological subtypes of MDE: Type I, consisting of ﬁne wrinkles
arranged parallel to the skin cleavage lines; and Type II, consisting ofa (R.M. Haber).
Inc. on behalf of Women's Dermatminiature, soft papular lesions made up of tiny perifollicular protru-
sions. Since that time, almost 90 cases of MDE have been reported
in the literature and, more recently, a third morphological subtype
has been described presenting with reticular erythema (Hillen, 2008;
Martin et al., 2008).
The aim of this review is to highlight the prevalence of MDE among
middle-aged healthy Caucasian females. In total, 10 new cases (13 pub-
lications) have been reported since Gambichler’s, 2010 review. Despite
the striking female predominance of MDE, a hormonal role in the
etiopathogenesis of this entity remains elusive.Case
A 45-year-old female was referred to our General Dermatology
Clinic for a second opinion regarding what was thought to be a case of
generalized atrophoderma by the referring dermatologist. The patient
noticed unusual, wrinkled skin on her arms ﬁrst beginning over 2
years earlier; wrinkling later began spreading to her trunk, back, and
proximal legs. Other than occasional pruritus, the skin ﬁndings were
asymptomatic and there was no preceding erythema.
Her past medical historywas unremarkable (of note, shewas nullip-
arous) and she had no recent travel. She was very active outdoors and
often exercised without sun protection. Shewas taking no medications,
including no oral contraceptives, and had no known allergies.
Physical examination revealed widespread papules and plaques
with wrinkling and mild protrusion from the surface of the skinologic Society. This is an open access article under the CC BY-NC-ND license (http://
Fig. 2. Flesh-colored, wrinkled papules and plaques on the back.
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and proximal arms and legs with sparing of her face and hands; it did
not appear to be photo-distributed (Fig. 2). She had ﬁner wrinkling of
the skin of her anterior shoulder areas (Fig. 3).
Histologically, Verhoeff–Van Gieson stains revealedmid-dermal loss
of elastic tissue (Figs. 4–6).
Discussion
Epidemiology and clinical presentation
Clinically, MDE predominantly affects the trunk, shoulders, back,
and upper extremities and usually spares the palms, soles, and face.
In Gambichler’s review, only 12.7% of patients had involvement of the
face and distal extremities (Martinez-Escala et al., 2012).
Of the 10 new reported cases, zero reported facial involvement and
all cases involved the abdomen and back with variable involvement
of neck and proximal extremities. Patients typically present with
asymptomatic, well-demarcated, symmetric ﬁne wrinkling of the skin
(Type I) and perifollicular papular protrusions (Type II). A third type,
an erythematous reticular variant, has more recently been described
(Bannister et al., 2001; Cutillas et al., 2010; Gambichler and Lubbe,
2012; Gambichler et al., 2010; Hillen, 2008; Martin et al., 2008; Meyer
et al., 2012; Posada et al., 2013).
Since Gambichler’s review in 2010, there have been 13 new
publications regarding MDE, but these cover only 10 novel clinical
cases, as Gambichler and colleagues wrote three distinct publications
all regarding the same clinical patient (Gambichler and Skrygan, 2013;
Gambichler et al., 2010; Scola et al., 2011). Furthermore, there were
two publications on MDE that did not report new clinical cases (El-
Khoury et al., 2014; Tong et al., 2013). Finally, there was one report of
two male patients with Type III MDE (Meyer et al., 2012). The remain-
der of the publications were novel cases of Type I and II MDE (Cohen
and Tschen, 2013; Cota et al., 2014; Lai et al., 2014; Martinez-Escala
et al., 2012) or Type III MDE (Cutillas et al., 2010; Gambichler and
Lubbe, 2012; Posada et al., 2013).
Epidemiologically, MDE affects Caucasian females predominantly
of North American and Central European origin (Gambichler, 2010).
Aside from twoAsian females and one Filipino female, all other reported
patients have been Caucasian (Cohen and Tschen, 2013; Suda et al.,Fig. 1. Flesh-colored, wrinkled papules and plaques withmild protrusion from the surface
of the skin.2008; Tajima et al., 1999). Gambichler (2010) reported an 83.5% female
prevalence in 2010, with a median age of 38 years. Since that time, 6 of
the 10 new reported cases have been female. Interestingly, of the publi-
cations since 2009, 6 of the 10were reports of Type III MDE. Unlike Type
I and Type II MDE, Type III demonstrates a strong male predominance,
with only three reported cases affecting females (Gambichler and
Lubbe, 2012; Gambichler et al., 2010; Posada et al., 2013). Therefore, if
the six recent reports of Type III MDE are removed (three of which
were in males), three of the four cases of Type I and II MDE since 2009
have been female. The only male presentation has been in an human
immunodeﬁciency virus–positive male suffering from immune recon-
stitution inﬂammatory syndrome (IRIS; Cota et al., 2014).
Like Shelley and Wood’s (1977) ﬁrst presentation, lesions are
preceded by erythema and/or burning that resolves, leaving well-
demarcated patches of ﬁne wrinkling in approximately 50% of cases of
MDE (Gambichler, 2010). In our case, the patient had little or no preced-
ing erythema and only occasional, inconsistent pruritus.
MDE has been reported in association with many inﬂammatory skin
conditions including urticaria (Fimiani et al., 1995; Shelley and Wood,
1977) and granuloma annulare (Adams and Mutasim, 2003), supporting
theories suggesting destruction of elastic ﬁbers by preceding inﬂammationFig. 3. Fine wrinkling on right upper-arm skin.
Fig. 4. Normal histology of hemotoxylin and eosin (H&E)–stained initial biopsy (40×
magniﬁcation).
Fig. 6. Verhoeff–van Giesson stain of affected skin revealing complete loss of elastic tissue
in the mid dermis, annotated with dotted lines (40× magniﬁcation).
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et al., 1994b; Neri et al., 1996; Rudolph, 1992; Shelley and Wood, 1977;
Suda et al., 2008).
Furthermore, in almost half of the cases reported, sun exposure was
implicated and/or the lesionswere photo-distributed (Agha et al., 1994;
Bannister et al., 2001; Fimiani et al., 1995; Gambichler, 2010; Patroi
et al., 2003; Snider et al., 1993). It is interesting that for a photo-
distributed eruption, the face is rarely affected. However, this is most
often the case as well in polymorphous light eruption, a condition that
is clearly photo-induced (Isedeh and Lim, 2013). Vatve et al. (2009) re-
ported a case of MDE following narrowband ultraviolet (UV) B therapy
for a ﬁrst episode of guttate psoriasis. However, there is often no histo-
logical evidence of chronic sun damage or involvement of chronically
sun-exposed sites. As a result, Snider et al. (1993) postulated that the
association of MDE to sun exposure is idiosyncratic and not related to
long-term sun exposure. Pregnancy or the use of contraceptives prior
to the onset of MDE was reported in 25% of patients, which may be
lower than expected given themedian andmode ages of females affect-
ed (Gambichler, 2010; Patroi et al., 2003).
Known associations and differential diagnosis
The association of MDE with rheumatoid arthritis (Rudolph, 1990),
false positive serology for Borrelia burgdorferi (Kirsner and Falanga,
1992), Hashimoto’s thyroiditis (Cozzani et al., 2009; Gambichler et al.,
1999; Patroi et al., 2003), Grave’s disease (Gambichler, 2010), systemicFig. 5. Verhoeff–van Gieson stain of normal skin showing normal elastic tissue (40×
magniﬁcation).lupus erythematosus (Boyd and King, 2001), positive antinuclear anti-
bodies (Tajima et al., 1999), protein S deﬁciency (Cozzani et al., 2009),
Type I diabetes, dermatitis herpetiformis, and antiphospholipid anti-
bodies (Martinez-Escala et al., 2012) lends support to an autoimmune
process in the pathogenesis of MDE. Martinez-Escala et al. treated
their patient with MDE who also had a positive antinuclear antibody
and antiphospholipid antibody syndrome with hydroxychloroquine
and noted cessation of progression of lesions after 4 months; after 10
months, the patient experienced regression of lesions on the upper ex-
tremities. Most recently, a 32 year-old HIV-positive male developed
MDE as a manifestation of IRIS, suggesting the inﬂammatory environ-
ment induced by IRIS and the loss of immune self-tolerance to tissue-
associated antigens may lead to increased susceptibility to develop
local and/or systemic pathological autoimmune conditions against elas-
tic ﬁbers (Cota et al., 2014).
The differential diagnosis for MDE includes anetoderma, annular
elastolytic giant cell granuloma, cutis laxa and cutis laxa-like syn-
dromes, and pseudoxanthoma elasticum-like papillary dermal elastosis
(Gambichler, 2010).
Histopathology, ultrastructure, and pathogenesis
A band-like focal loss of elastic ﬁbers along the mid-dermis is the
characteristic histopathological diagnostic feature of MDE. Biopsies
sent for hematoxylin and eosin staining are commonly reported as nor-
mal, and the clinician must prompt the pathologist to pursue orcein or
van Gieson staining. This was the case in our patient, as initial biopsies
by a referringdermatologistwere nonspeciﬁc; itwas only after thediag-
nosis of MDE was suggested that the dermatopathologist ordered the
elastic tissue stains, which demonstrated classic pathology of MDE.
Thepapillary anddeeper reticulardermis areunaffectedandelastic tissue re-
mains intact around appendages, even with Type II MDE (Gambichler et al.,
1999;Maghraoui et al., 1994a). There is no evidence of dermal actinic damage
such as elastosis. Inﬂammatory inﬁltrates, most often lymphocytic and
perivascular, are more commonly seen in Type III MDE (Bannister et al., 2001;
Hillen, 2008; Martin et al., 2008). Interstitial histiocytes, multinucleated giant
cells, and occasional ﬁgures of elastophagocytosis have been reported (Neri
et al., 1996). Interestingly, it has been observed that the degree of histological in-
ﬂammationparallels thepresenceof elastophagocytosis (Patroi et al., 2003;Tong
et al., 2013).
Ultrastructural studies have demonstrated phagocytosis of
degenerated abnormal elastic ﬁbers by macrophages, a loose assembly
of skeleton ﬁbrils, and irregular aggregations of dense substance
(Agha et al., 1994; Fimiani et al., 1995; Gambichler, 2010; Neri et al.,
1996; Sterling et al., 1994). Immunohistochemical studies have demon-













Fig. 7. An imbalance between metalloproteinases (MMPs) and tissue-inhibitor of
metalloproteinases (TIMP) is suspected in the pathogenesis of MDE. (1) In MDE lesional
skin there is an increased number of CD68+ and CD34+ histiocytes. (2) There is also in-
creased expression of MMP-1, MMP-9, and MMP-12 with decreased elastase inhibitor
TIMP-1. (3) Ultraviolet B, infrared, and visible light are hypothesized to play a role in alter-
ation of MMP expression. (4) Disruption of this balance is thought to lead to degradative
processes such as increased elastolysis in MDE.
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Patroi et al., 2003). Gambichler et al. found elevated cellular expression of
MMP-1(matrixmetalloproteinase-1)andMMP-12 in lesional skinwithde-
creased tissue-inhibitor of metalloproteinases 1 (TIMP-1). Patroi et al. re-
ported elastin, but not ﬁbrillin-1, immunoreactivity disappearing from the
mid-dermis, as well as MMP-9 in epidermal keratinocytes and in the cyto-
plasm of large, multinucleated cells located in lesional dermis. Suda et al.
(2008) found numerous CD68+ and MMP-9-producing histiocytes and
giant cells in erythematous MDE lesions, with few CD68+ in wrinkled
skin. As a result, the authors concluded MDE may be initiated by MMP-9
produced by histiocytes and giant cells through its degradation of elastic
ﬁbers.
The pathogenesis of MDE is not well understood, but has been postu-
lated to be related to induction of matrix metalloproteinases. Matrix me-
talloproteinases (MMPs) play a central role in the physiologic and timely
breakdown of extracellular matrix essential for embryonic development,
morphogenesis, reproduction, and tissue resorption and remodeling
(Nagase andWoessner, 1999). The expressionofmostmatrixmetallopro-
teinases is transcriptionally regulated by growth factors, hormones, cyto-
kines, and cellular transformation. The proteolytic activities of MMPs are
precisely controlled by endogenous inhibitors,α-macroglobulins, and tis-
sue inhibitors of metalloproteinases (TIMPs). Soluble factor, cell–matrix,
and cell–cell interactions are all involved in the complex nature of MMP
induction (Nagase and Woessner, 1999). The balance between activated
MMPs and TIMPs determines the overall MMP proteolytic activity and,
consequently, the extent of extracellular matrix degradation. Further,
local disruption of this balance can lead to pathological degradative
processes such as increased elastolysis. Several studies have speculated
an imbalance in MMP–TIMP activity in MDE (Gambichler et al., 2004;
Patroi et al., 2003). More speciﬁcally, matrix metalloproteinases
gelatinase A (MMP-2) and gelatinase B (MMP-9) are implicated in the
physiological and pathological breakdown of several extracellular matrix
proteins (Baldwin et al., 2013; Isnard et al., 2002). Cultured ﬁbroblasts
from MDE lesional skin have demonstrated increased synthesis of elas-
tases (Fimiani et al., 1995; Prigent et al., 1993; Tajima et al., 1999). As
such, Gambichler (2010) hypothesized that decreased elastase inhibition
combined with increased MMP activity followed by elastophagocytosis
may constitute the background on which MDE can arise. In addition to
MMPs, the lysyl oxidase (LOX) family has also been found to be responsi-
ble for the formation of collagen and elastin ﬁbrils in the extracellularma-
trix. In addition to LOX, four LOX-like (LOXL) proteins have also been
identiﬁed and play a role in biosynthesis and renewal of elastic tissue.
Gambichler and Skrygan (2013) found increased MMP-9 expression de-
creased LOXL2 mRNA levels in lesional MDE skin.
Whether ultraviolet radiation or hormonal triggers are pathogenic fac-
tors inMDE remains unknown. Certainly, a hormonal and/or UV-induced
alteration in MMPs could potentially explain the unequivocal proportion
of female patients reported, aswell as the signiﬁcant history of sun or tan-
ning bed exposure amongst them. Brenneisen et al. (2002) reportedUVB-
triggered induction of MMP-1 and MMP-3 and, subsequently, Brennan
et al. (2003) found increased MMP-1 levels in punch biopsies of human
skin obtained 1 day after irradiation with two minimal erythema doses
of UVB. Cho et al. (2008) observed that infrared/visible light spectrum
of sunlight signiﬁcantly increased MMP-1 and MMP-9 expression. Inter-
estingly, endogenous estrogen was found to exacerbate UV-induced in-
ﬂammation and photo-aging in mice (Yoon et al., 2014). However, to
our knowledge, the only study currently published linking estrogen to
MMPs evaluated the role of estrogen on osteoarthritic chondrocytes and
actually found that estrogen was protective and may improve the imbal-
ance between the amounts of MMPs and TIMPs in the chondrocytes of
postmenopausal osteoarthritic females (Fig. 7; Lee et al., 2003).
Imaging and investigations
Noninvasive imaging methods, such as coherence tomography
and high frequency ultrasound, are potential new modalities recentlyreported to be of use in evaluating MDE (Scola et al., 2011). Further,
multiphoton microscopy, which uses near-infrared light to visualize
deep tissues and exploit autoﬂuorescent extracellular matrix ﬁbers,
has been used to calculate and three-dimensionally quantify elastic
ﬁbers (Tong et al., 2013).
Treatment
Unfortunately, there are no reports of efﬁcacious treatment forMDE.
In fact, most studies do not report on treatmentmodalities, likely owing
to the benign course of MDE. Use of topical and systemic steroids (Boyd
and King, 2001; Lewis et al., 2004), colchicine (Sterling et al., 1994), and
tretinoin (Harmon et al., 1994; Sterling et al., 1994) have been reported.
Topical tretinoin seems to be themostwidely used and has been report-
ed to reduce wrinkles, but not to alter the natural history of the disease
(Sterling et al., 1994). As previously mentioned, Martinez-Escala et al.
(2012) reported a patient with positive ANA and antiphospholipid anti-
body syndrome who had cessation of progression of lesions after 4
months and regression of lesions on the upper extremities after 10
months with hydroxychloroquine.
Novel natural therapies include soybeanextract and eicosapentanoic
acid (EPA). Mouse and swine skins topically treated with soybean ex-
tracts showed enhanced elastic ﬁber network and inhibition of elas-
tases. Further, elastin expression was also augmented in human skin
transplanted onto immunodeﬁcient mice in response to soy treatment
(Zhao et al., 2009). Topical EPA has been found to inhibit UV-induced
MMP-1 expression in dermal ﬁbroblasts as well as increase collagen
and elastic ﬁbers (tropoelastin and ﬁbrillin-1; Kim et al., 2006). Where-
asMDE does not alter ﬁbrillinmicroﬁbrils, EPAmay be a potential agent
for the treatment of MDE.
Lastly, the cosmetic implications of MDE can be life altering and cli-
nicians should not neglect the psychosocial impact of this diagnosis.
Conclusion
Mid-dermal elastolysis is a clinical and histological diagnosis that
predominantly affects young, healthy females. Its pathogenesis remains
elusive, although potential theories suggest correlation with sun expo-
sure as well as autoimmunity. Clinicians may be tempted to diminish
the severity of this diagnosis as there are no systemic manifestations.
130 J. Hardin et al. / International Journal of Women's Dermatology 1 (2015) 126–130However, they need to be aware of the dramatic cosmetic implications
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